The expression of Bcl-2 family members is not only closely associated with the androgen-independent phenotype of prostate cancers but also confers an anti-apoptotic capability against androgen withdrawal and cytotoxic chemotherapy (21). The gene discussed is BCL2; the disease is Familial prostate cancer.